Regulation of Cellular Antiviral Signaling by Modifications of Ubiquitin and Ubiquitin-like Molecules

키워드

참고문헌 (141)

1. Janeway CA Jr, "Approaching the asymptote? Evolution and revolution in immunology", Cold Spring Harb Symp Quant Biol, 54, pp.1~13 (1989)[DOI]
2. Takeuchi O, "Pattern recognition receptors and inflammation", Cell, 140, pp.805~820 (2010)[DOI]
3. Wu J, "Innate immune sensing and signaling of cytosolic nucleic acids", Annu Rev Immunol, 32, pp.461~488 (2014)[DOI]
4. Kawai T, "IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction", Nat Immunol, 6, pp.981~988 (2005)[DOI]
5. Meylan E, "Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus", Nature, 437, pp.1167~1172 (2005)[DOI]
6. Xu LG, "VISA is an adapter protein required for virus-triggered IFN-beta signaling", Mol Cell, 19, pp.727~740 (2005)[DOI]
7. Seth RB, "Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3", Cell, 122, pp.669~682 (2005)[DOI]
8. Sun L, "Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway", Science, 339, pp.786~791 (2013)[DOI]
9. Li XD, "Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects", Science, 341, pp.1390~1394 (2013)[DOI]
10. Chiu YH, "RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway", Cell, 138, pp.576~591 (2009)[DOI]
11. Ablasser A, "RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate", Nat Immunol, 10, pp.1065~1072 (2009)[DOI]
12. Zhong B, "The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation", Immunity, 29, pp.538~550 (2008)[DOI]
13. Ishikawa H, "STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling", Nature, 455, pp.674~678 (2008)[DOI]
14. Man SM, "Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases", Immunol Rev, 277, pp.61~75 (2017)[DOI]
15. Yang J, "Post-translational regulation of inflammasomes", Cell Mol Immunol, 14, pp.65~79 (2017)[DOI]
16. Komander D, "The ubiquitin code", Annu Rev Biochem, 81, pp.203~229 (2012)[DOI]
17. Mevissen TE, "Mechanisms of deubiquitinase specificity and regulation", Annu Rev Biochem, 86, pp.159~192 (2017)[DOI]
18. Enchev RI, "Protein neddylation: beyond cullin-RING ligases", Nat Rev Mol Cell Biol, 16, pp.30~44 (2015)
19. dos Santos PF, "Beyond ISGlylation: functions of free intracellular and extracellular ISG15", J Interferon Cytokine Res, 37, pp.246~253 (2017)[DOI]
20. Dhingra N, "A guide for targeted SUMO removal", Genes Dev, 31, pp.719~720 (2017)[DOI]
21. Xia P, "IRTKS negatively regulates antiviral immunity through PCBP2 sumoylation-mediated MAVS degradation", Nat Commun, 6, pp.8132~ (2015)[DOI]
22. Yang P, "CpG site-specific hypermethylation of <TEX>$p16INK4{\alpha}$<", TEX> in peripheral blood lymphocytes of PAH-exposed workers, 2012, pp.21, 182~190
23. Skaug B, "Emerging role of ISG15 in antiviral immunity", Cell, 143, pp.187~190 (2010)[DOI]
24. Liu B, "The ubiquitin E3 ligase TRIM31 promotes aggregation and activation of the signaling adaptor MAVS through Lys63-linked polyubiquitination", Nat Immunol, 18, pp.214~224 (2017)
25. Wang Q, "The E3 ubiquitin ligase AMFR and INSIG1 bridge the activation of TBK1 kinase by modifying the adaptor STING", Immunity, 41, pp.919~933 (2014)[DOI]
26. Zhang J, "TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA", STING protein for K63-linked ubiquitination, 2012, pp.287, 28646~28655
27. Tsuchida T, "The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA", Immunity, 33, pp.765~776 (2010)[DOI]
28. Michallet MC, "TRADD protein is an essential component of the RIG-like helicase antiviral pathway", Immunity, 28, pp.651~661 (2008)[DOI]
29. Liu S, "MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades", ELife, 2, pp.e00785~ (2013)
30. Liu S, "Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation", Science, 347, pp.aaa2630~ (2015)[DOI]
31. Shinohara ML, "Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells", Nat Immunol, 7, pp.498~506 (2006)[DOI]
32. Honda K, "IRF-7 is the master regulator of type-I interferon-dependent immune responses", Nature, 434, pp.772~777 (2005)[DOI]
33. Honda K, "Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction", Nature, 434, pp.1035~1040 (2005)[DOI]
34. Lu B, "Induction of INKIT by viral infection negatively regulates antiviral responses through inhibiting phosphorylation of p65 and IRF3", Cell Host Microbe, 22, pp.86~98.e4 (2017)[DOI]
35. Jin J, "Noncanonical <TEX>$NF-{\kappa}B$<", TEX> pathway controls the production of type I interferons in antiviral innate immunity, 2014, pp.40, 342~354
36. Anukriti Mathur, "Molecular mechanisms of inflammasome signaling", Journal of Leukocyte Biology, pp.jlb.3MR0617-250R~ (2017), Wiley[DOI]
37. Schroder K, "The inflammasomes", Cell, 140, pp.821~832 (2010)[DOI]
38. Rathinam VA, "The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses", Nat Immunol, 11, pp.395~402 (2010)[DOI]
39. Singh VV, "Kaposi's sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes", J Virol, 87, pp.4417~4431 (2013)[DOI]
40. Johnson KE, "Herpes simplex virus 1 infection induces activation and subsequent inhibition of the IFI16 and NLRP3 inflammasomes", J Virol, 87, pp.5005~5018 (2013)[DOI]
41. Poeck H, "Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production", Nat Immunol, 11, pp.63~69 (2010)[DOI]
42. Chattergoon MA, "HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon", PLoS Pathog, 10, pp.e1004082~ (2014)[DOI]
43. Ogura Y, "The inflammasome: first line of the immune response to cell stress", Cell, 126, pp.659~662 (2006)[DOI]
44. Oda T, "Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD", Science, 244, pp.974~976 (1989)[DOI]
45. Ichinohe T, "Influenza virus activates inflammasomes via its intracellular M2 ion channel", Nat Immunol, 11, pp.404~410 (2010)
46. Rahman MM, "Myxoma virus lacking the pyrin-like protein M013 is sensed in human myeloid cells by both NLRP3 and multiple Toll-like receptors, which independently activate the inflammasome and <TEX>$NF-{\kappa}B$<", TEX> innate response pathways, 2011, pp.85, 12505~12517
47. Martin BN, "<TEX>$IKK{\alpha}$<", TEX> negatively regulates ASC-dependent inflammasome activation, 2014, pp.5, 4977~
48. Wang Y, "Inflammasome activation triggers caspase-1-mediated cleavage of cGAS to regulate responses to DNA virus infection", Immunity, 46, pp.393~404 (2017)[DOI]
49. Lin D, "Regulation of cellular innate antiviral signaling by ubiquitin modification", Acta Biochim Biophys Sin (Shanghai), 47, pp.149~155 (2015)[DOI]
50. Liu W, "Cyclophilin A-regulated ubiquitination is critical for RIG-I-mediated antiviral immune responses", ELife, 6, pp.e24425~ (2017)
51. Gack MU, "TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity", Nature, 446, pp.916~920 (2007)[DOI]
52. Shi Y, "Ube2D3 and Ube2N are essential for RIG-I-mediated MAVS aggregation in antiviral innate immunity", Nat Commun, 8, pp.15138~ (2017)[DOI]
53. Sun X, "A hierarchical mechanism of RIG-I ubiquitination provides sensitivity, robustness and synergy in antiviral immune responses", Sci Rep, 6, pp.29263~ (2016)[DOI]
54. Xian H, "Stratified ubiquitination of RIG-I creates robust immune response and induces selective gene expression", Sci Adv, 3, pp.e1701764~ (2017)[DOI]
55. Hao Q, "A non-canonical role of the p97 complex in RIG-I antiviral signaling", EMBO J, 34, pp.2903~2920 (2015)[DOI]
56. Wang W, "RNF122 suppresses antiviral type I interferon production by targeting RIG-I CARDs to mediate RIG-I degradation", Proc Natl Acad Sci U S A, 113, pp.9581~9586 (2016)[DOI]
57. Arimoto K, "Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125", Proc Natl Acad Sci U S A, 104, pp.7500~7505 (2007)[DOI]
58. Chen W, "Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation", Cell, 152, pp.467~478 (2013)[DOI]
59. Zhao C, "The E3 ubiquitin ligase TRIM40 attenuates antiviral immune responses by targeting MDA5 and RIG-I", Cell Rep, 21, pp.1613~1623 (2017)[DOI]
60. Zhang H, "Ubiquitin-specific protease 15 negatively regulates virus-induced type I interferon signaling via catalytically-dependent and -independent mechanisms", Sci Rep, 5, pp.11220~ (2015)[DOI]
61. Pauli EK, "The ubiquitin-specific protease USP15 promotes RIG-I-mediated antiviral signaling by deubiquitylating TRIM25", Sci Signal, 7, pp.ra3~ (2014)[DOI]
62. Zhang M, "Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD", J Biol Chem, 283, pp.18621~18626 (2008)[DOI]
63. Chen R, "The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling", Cell Res, 20, pp.802~811 (2010)[DOI]
64. Wang L, "USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I", J Virol, 87, pp.4507~4515 (2013)[DOI]
65. Cui J, "USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptors", Cell Res, 24, pp.400~416 (2014)[DOI]
66. Fan Y, "USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase", J Exp Med, 211, pp.313~328 (2014)[DOI]
67. Lang X, "TRIM65-catalized ubiquitination is essential for MDA5-mediated antiviral innate immunity", J Exp Med, 214, pp.459~473 (2017)[DOI]
68. Wang Q, "The E3 ubiquitin ligase RNF185 facilitates the cGAS-mediated innate immune response", PLoS Pathog, 13, pp.e1006264~ (2017)[DOI]
69. Chen M, "TRIM14 inhibits cGAS degradation mediated by selective autophagy receptor p62 to promote innate immune responses", Mol Cell, 64, pp.105~119 (2016)[DOI]
70. Shi CS, "Activation of autophagy by inflammatory signals limits IL-<TEX>$1{\beta}$<", TEX> production by targeting ubiquitinated inflammasomes for destruction, 2012, pp.13, 255~263
71. Han S, "Lipopolysaccharide primes the NALP3 inflammasome by inhibiting its ubiquitination and degradation mediated by the SCFFBXL2 E3 ligase", J Biol Chem, 290, pp.18124~18133 (2015)[DOI]
72. Yan Y, "Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome", Cell, 160, pp.62~73 (2015)[DOI]
73. Xue Q, "TRIM38 negatively regulates TLR3-mediated IFN-<TEX>${\beta}$<", TEX> signaling by targeting TRIF for degradation, 2012, pp.7, e46825~
74. Hu MM, "TRIM38 negatively regulates TLR3", 4-mediated innate immune and inflammatory responses by two sequential and distinct mechanisms, 2015, pp.195, 4415~4425
75. Yang Y, "E3 ligase WWP2 negatively regulates TLR3-mediated innate immune response by targeting TRIF for ubiquitination and degradation", Proc Natl Acad Sci U S A, 110, pp.5115~5120 (2013)[DOI]
76. Yang Q, "TRIM32-TAX1BP1-dependent selective autophagic degradation of TRIF negatively regulates TLR3", 4-mediated innate immune responses, 2017, pp.13, e1006600~
77. Lee BC, "Deubiquitinase CYLD acts as a negative regulator for bacterium NTHi-induced inflammation by suppressing K63-linked ubiquitination of MyD88", Proc Natl Acad Sci U S A, 113, pp.E165~E171 (2016)[DOI]
78. Naiki Y, "Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling", J Biol Chem, 280, pp.5491~5495 (2005)[DOI]
79. Strickson S, "The anti-inflammatory drug BAY 11-7082 suppresses the MyD88-dependent signalling network by targeting the ubiquitin system", Biochem J, 451, pp.427~437 (2013)[DOI]
80. Ji S, "Cell-surface localization of Pellino antagonizes Toll-mediated innate immune signalling by controlling MyD88 turnover in Drosophila", Nat Commun, 5, pp.3458~ (2014)[DOI]
81. Wang C, "The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon", Nat Immunol, 10, pp.744~752 (2009)[DOI]
82. Jin S, "Tetherin suppresses type I interferon signaling by targeting MAVS for NDP52-mediated selective autophagic degradation in human cells", Mol Cell, 68, pp.308~322 (2017)[DOI]
83. Xing J, "TRIM29 promotes DNA virus infections by inhibiting innate immune response", Nat Commun, 8, pp.945~ (2017)[DOI]
84. Ni G, "Ubiquitination of STING at lysine 224 controls IRF3 activation", Sci Immunol, 2, pp.eaah7119~ (2017)[DOI]
85. Wang Y, "<TEX>$TRIM30{\alpha}$<", TEX> is a negative-feedback regulator of the intracellular DNA and DNA virus-triggered response by targeting STING, 2015, pp.11, e1005012~
86. Zhang M, "USP18 recruits USP20 to promote innate antiviral response through deubiquitinating STING", MITA, 2016, pp.26, 1302~1319
87. Sun H, "USP13 negatively regulates antiviral responses by deubiquitinating STING", Nat Commun, 8, pp.15534~ (2017)[DOI]
88. Chen Y, "p38 inhibition provides anti-DNA virus immunity by regulation of USP21 phosphorylation and STING activation", J Exp Med, 214, pp.991~1010 (2017)[DOI]
89. Mao AP, "Virus-triggered ubiquitination of TRAF3", 6 by cIAP1, J Biol Chem, pp.2010, 285[DOI]
90. Wang C, "Estrogen receptor alpha inhibits RLR-mediated immune response via ubiquitinating TRAF3", Cell Signal, 27, pp.1977~1983 (2015)[DOI]
91. Peng Y, "HSCARG negatively regulates the cellular antiviral RIG-I like receptor signaling pathway by inhibiting TRAF3 ubiquitination via recruiting OTUB1", PLoS Pathog, 10, pp.e1004041~ (2014)[DOI]
92. Li S, "Regulation of virus-triggered signaling by OTUB1- and OTUB2-mediated deubiquitination of TRAF3 and TRAF6", J Biol Chem, 285, pp.4291~4297 (2010)[DOI]
93. Lin D, "Induction of USP25 by viral infection promotes innate antiviral responses by mediating the stabilization of TRAF3 and TRAF6", Proc Natl Acad Sci U S A, 112, pp.11324~11329 (2015)[DOI]
94. Panda S, "Deubiquitinase MYSM1 regulates innate immunity through inactivation of TRAF3 and TRAF6 complexes", Immunity, 43, pp.647~659 (2015)[DOI]
95. Guan K, "MAVS promotes inflammasome activation by targeting ASC for K63-linked ubiquitination via the E3 ligase TRAF3", J Immunol, 194, pp.4880~4890 (2015)[DOI]
96. An T, "DYRK2 negatively regulates type I interferon induction by promoting TBK1 degradation via Ser527 phosphorylation", PLoS Pathog, 11, pp.e1005179~ (2015)[DOI]
97. Wildling L, "Linking of sensor molecules with amino groups to amino-functionalized AFM tips", Bioconjug Chem, 22, pp.1239~1248 (2011)[DOI]
98. Song G, "E3 ubiquitin ligase RNF128 promotes innate antiviral immunity through K63-linked ubiquitination of TBK1", Nat Immunol, 17, pp.1342~1351 (2016)[DOI]
99. Zhao X, "c-Cbl-mediated ubiquitination of IRF3 negatively regulates IFN-<TEX>${\beta}$<", TEX> production and cellular antiviral response, 2016, pp.28, 1683~1693
100. Chattopadhyay S, "Ubiquitination of the transcription factor IRF-3 activates RIPA, the apoptotic pathway that protects mice from viral pathogenesis", Immunity, 44, pp.1151~1161 (2016)[DOI]
101. Ning S, "TRAF6 and the three C-terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein 1", Mol Cell Biol, 28, pp.6536~6546 (2008)[DOI]
102. Decque A, "Sumoylation coordinates the repression of inflammatory and anti-viral gene-expression programs during innate sensing", Nat Immunol, 17, pp.140~149 (2016)
103. Mi Z, "SUMOylation of RIG-I positively regulates the type I interferon signaling", Protein Cell, 1, pp.275~283 (2010)[DOI]
104. Fu J, "MDA5 is SUMOylated by <TEX>$PIAS2{\beta}$<", TEX> in the upregulation of type I interferon signaling, 2011, pp.48, 415~422
105. Doiron K, "The dynamic interacting landscape of MAPL reveals essential functions for SUMOylation in innate immunity", Sci Rep, 7, pp.107~ (2017)[DOI]
106. Hu MM, "Innate immunity to RNA virus is regulated by temporal and reversible sumoylation of RIG-I and MDA5", J Exp Med, 214, pp.973~989 (2017)[DOI]
107. Hu MM, "Sumoylation promotes the stability of the DNA sensor cGAS and the adaptor STING to regulate the kinetics of response to DNA virus", Immunity, 45, pp.555~569 (2016)[DOI]
108. Cui Y, "SENP7 potentiates cGAS activation by relieving SUMO-mediated inhibition of cytosolic DNA sensing", PLoS Pathog, 13, pp.e1006156~ (2017)[DOI]
109. Sankineni S, "Does pIgR down-regulation in COPD cause reprogramming of bronchial epithelium?", Lung, 193, pp.1~2 (2015)[DOI]
110. Kubota T, "Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression", J Biol Chem, 283, pp.25660~25670 (2008)[DOI]
111. Liang Q, "Tripartite motif-containing protein 28 is a small ubiquitin-related modifier E3 ligase and negative regulator of IFN regulatory factor 7", J Immunol, 187, pp.4754~4763 (2011)[DOI]
112. Li R, "PIAS1 negatively modulates virus triggered type I IFN signaling by blocking the DNA binding activity of IRF3", Antiviral Res, 100, pp.546~554 (2013)[DOI]
113. Lumpkin RJ, "Site-specific identification and quantitation of endogenous SUMO modifications under native conditions", Nat Commun, 8, pp.1171~ (2017)[DOI]
114. Lamoliatte F, "Uncovering the SUMOylation and ubiquitylation crosstalk in human cells using sequential peptide immunopurification", Nat Commun, 8, pp.14109~ (2017)[DOI]
115. Lenschow DJ, "IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses", Proc Natl Acad Sci U S A, 104, pp.1371~1376 (2007)[DOI]
116. Ritchie KJ, "Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection", Nat Med, 10, pp.1374~1378 (2004)[DOI]
117. Ketscher L, "Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance", Proc Natl Acad Sci U S A, 112, pp.1577~1582 (2015)[DOI]
118. Arimoto K, "UbcH8 regulates ubiquitin and ISG15 conjugation to RIG-I", Mol Immunol, 45, pp.1078~1084 (2008)[DOI]
119. Lu G, "ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation", Cell Mol Biol (Noisy-le-grand), 52, pp.29~41 (2006)
120. Shi HX, "Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification", Mol Cell Biol, 30, pp.2424~2436 (2010)[DOI]
121. Werneke SW, "ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation", PLoS Pathog, 7, pp.e1002322~ (2011)[DOI]
122. Bogunovic D, "Mycobacterial disease and impaired IFN-<TEX>${\gamma}$<", TEX> immunity in humans with inherited ISG15 deficiency, 2012, pp.337, 1684~1688
123. Zhang X, "Human intracellular ISG15 prevents interferon-<TEX>${\alpha}", {\beta}$<, Nature, pp.2015, 517[DOI]
124. Meuwissen ME, "Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome", J Exp Med, 213, pp.1163~1174 (2016)[DOI]
125. Strebovsky J, "Suppressor of cytokine signaling 1 (SOCS1) limits NFkappaB signaling by decreasing p65 stability within the cell nucleus", FASEB J, 25, pp.863~874 (2011)[DOI]
126. Chang PJ, "Effects of the NEDD8-activating enzyme inhibitor MLN4924 on lytic reactivation of Kaposi's sarcoma-associated herpesvirus", J Virol, 91, pp.505~517 (2017)
127. Davis KA, "Rotavirus NSP1 requires casein kinase II-mediated phosphorylation for hijacking of cullin-RING ligases", MBio, 8, pp.1213~1217 (2017)
128. Ding S, "Comparative proteomics reveals strain-specific <TEX>${\beta}$<", TEX>-TrCP degradation via rotavirus NSP1 hijacking a host cullin-3-Rbx1 complex, 2016, pp.12, e1005929~
129. Coleman KE, "SENP8 limits aberrant neddylation of NEDD8 pathway components to promote cullin-RING ubiquitin ligase function", ELife, 6, pp.e24325~ (2017)
130. Noguchi K, "TRIM40 promotes neddylation of <TEX>$IKK{\gamma}$<", TEX> and is downregulated in gastrointestinal cancers, 2011, pp.32, 995~1004
131. Yan F, "MyD88 NEDDylation negatively regulates MyD88-dependent <TEX>$NF-{\kappa}B$<", TEX> signaling through antagonizing its ubiquitination, 2017, pp.482, 632~637
132. Chan Y, "DEN1 deneddylates non-cullin proteins in vivo", J Cell Sci, 121, pp.3218~3223 (2008)[DOI]
133. Mendoza HM, "NEDP1, a highly conserved cysteine protease that deNEDDylates Cullins", J Biol Chem, 278, pp.25637~25643 (2003)[DOI]
134. Wu K, "DEN1 is a dual function protease capable of processing the C terminus of Nedd8 and deconjugating hyper-neddylated CUL1", J Biol Chem, 278, pp.28882~28891 (2003)[DOI]
135. Puja Kumari, "Viral deubiquitinases: role in evasion of anti-viral innate immunity", Critical Reviews in Microbiology, 44(3), pp.304~317 (2018), Informa UK Limited[DOI]
136. Zhao K, "Cytoplasmic STAT4 promotes antiviral type I IFN production by blocking CHIP-mediated degradation of RIG-I", J Immunol, 196, pp.1209~1217 (2016)[DOI]
137. Ye JS, "Lysine 63-linked TANK-binding kinase 1 ubiquitination by mindbomb E3 ubiquitin protein ligase 2 is mediated by the mitochondrial antiviral signaling protein", J Virol, 88, pp.12765~12776 (2014)[DOI]
138. Yu Z, "USP1-UAF1 deubiquitinase complex stabilizes TBK1 and enhances antiviral responses", J Exp Med, 214, pp.3553~3563 (2017)[DOI]
139. Cui J, "NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4", Nat Immunol, 13, pp.387~395 (2012)[DOI]
140. Saul VV, "SUMO modification of TBK1 at the adaptor-binding C-terminal coiled-coil domain contributes to its antiviral activity", Biochim Biophys Acta, 1853, pp.136~143 (2015)[DOI]
141. Duong BH, "A20 restricts ubiquitination of pro-interleukin-<TEX>$1{\beta}$<", TEX> protein complexes and suppresses NLRP3 inflammasome activity, 2015, pp.42, 55~67

관련 논문AI추천